Study helps explain how xanthan gum, a common food additive, is processed in the gut
A new study examines the ability of the human gut microbiome to digest xanthan gum, a relatively recently introduced food ingredient found in many processed foods.
A drug that treats alcoholism may be the next anti-anxiety medication
Disulfiram is a drug used to treat chronic alcoholism. However, studies suggest that it also inhibits chemokine receptor signaling pathways that are associated with the regulation of anxiety in rodents. Now, researchers show that disulfiram can effecti…
Lies that ‘might’ eventually come true seem less unethical
People may be willing to condone statements they know to be false and even spread misinformation on social media if they believe those statements could become true in the future, according to new research.
Graphene-hBN breakthrough to spur new LEDs, quantum computing
In a discovery that could speed research into next-generation electronics and LED devices, a research team has developed a reliable, scalable method for growing single layers of hexagonal boron nitride on graphene.
Study tracks COVID-19 antibodies over time
A new study of COVID-19 antibodies shows that Pfizer vaccine antibodies fall faster than Moderna — and for Pfizer recipients, age matters.
Researchers create miniature wide-angle camera with flat metalenses
Researchers have designed a new, ultrathin camera that acquires wide-angle, high-quality images using a metalens array. This approach eliminates bulky and heavy lenses, possibly enabling the incorporation of wide-angle cameras into smartphones and othe…
Here’s Why Snap Is Outperforming Pinterest in 2022
The social media peers are experiencing different impacts from the economy’s reopening.
Has Your Home Gone Through Foreclosure? Get It Right With the IRS Before Tax Season Ends
Your days of paying bills on that foreclosed home may not be over yet.
Should You Give Up on Novavax?
The company is waiting for an important decision.
Helping Investors Understand Cash Flow
Motley Fool senior analyst John Rotonti continues his discussion on the most important financial statements, focusing on the cash flow statement and what it reveals to investors.
Food insecurity doubled likelihood of foregoing or delaying medical care during first year of COVID-19 pandemic in U.S.
Individuals with food insecurity were also two to three times more likely to have delayed or foregone specific types of care, including skipping a recommended treatment, test or follow-up visit, and not filling a prescription, according to a new study.
Home Depot Looks Like a Fat Pitch
Down 27% from their high, Home Depot shares may be offering investors a fat pitch.
Meta Platforms Just Made a Big Move in the Metaverse
Investors are going to like this monetization-focused move by Meta Platforms.
3 Growth Stocks You Can Buy Right Now With Less Than $100
Investors don’t have to shell out a small fortune to own several shares of a high-octane company.
3 Dividend Kings to Hold Until You’re Blue in the Face
These long-term performers should still reward the buy-and-holders.
2 Reasons to Buy Repligen, and 1 Reason to Sell
Management has executed its strategy well, but a potential risk is looming.
If You’d Invested $1,000 in Twitter in 2013, This Is How Much You Would Have Today
The social media company has generated mediocre returns.
Meta May Already Be Set Up to Fail in the Metaverse
Meta has made the right statements publicly to be a metaverse leader, but its actions leave a lot to be desired.
2 Growth Stocks to Buy and Hold Forever
Investors can rest easy while padding their wallets with these dynamic growth stocks.
These 3 Supercharged Growth Stocks Have This Trait in Common
The growth-at-all-costs philosophy is not in favor with investors right now.